title: The association of anti-phospholipid antibodies with parity in placental malaria.
abstract: Anti-phospholipid antibodies (aPL) are autoantibodies associated with both infections and the pathogenesis of certain pregnancy complications. In the latter, but not the former, aPL are dependent on a co-factor, beta(2) glycoprotein I (beta2GPI), which can also be used as an antigen for detection of such aPL in pregnancy. A cross-sectional study was carried out on serum samples from Kumasi, Ghana, to determine the occurrence and beta2GPI-dependence of aPL in placental malaria. Anti-cardiolipin, anti-phosphatidylserine and anti-beta2GPI enzyme-linked immunosorbent assays (ELISAs) were performed on sera from 103 HIV-non-infected gravid women. Placental malaria, both active and past infection, was diagnosed in 33/103 (32%) based on placental histology. In multiparae, beta2GPI-independent IgM antibodies to cardiolipin (P = 0.018) and phosphatidylserine (P = 0.009) were observed, which were most pronounced in past placental malaria infection. In primiparae, no association emerged between aPL and placental malaria. Trends for improved clinical parameters were identified in infected women with levels of anti-cardiolipin beyond the 99th multiple of the median for a healthy, non-malarious population. This study in placental malaria reports parity associations of beta2GPI-independent aPL profiles, and does not support a role for beta2GPI-dependent aPL. It is of significance in the context of the known parity differences in pregnancy malaria immunity.
authors.affiliation: MRC Laboratories, Atlantic Road, Fajara, The Gambia.
authors.forename: S
authors.initials: S
authors.lastname: Owens
authors.forename: L W
authors.initials: LW
authors.lastname: Chamley
authors.forename: J
authors.initials: J
authors.lastname: Ordi
authors.forename: B J
authors.initials: BJ
authors.lastname: Brabin
authors.forename: P M
authors.initials: PM
authors.lastname: Johnson
mesh_terms: D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000276:immunology; D017152:Antibodies, Antiphospholipid / Q000276:immunology*; D000925:Anticoagulants / Q000276:immunology; D001053:Apolipoproteins / Q000276:immunology; D002308:Cardiolipins / Q000276:immunology; D003430:Cross-Sectional Studies; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008288:Malaria / Q000276:immunology*; D010298:Parity / Q000276:immunology*; D010718:Phosphatidylserines / Q000276:immunology; D010922:Placenta Diseases / Q000276:immunology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology*; D053482:beta 2-Glycoprotein I
chemical_list: D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D001053:Apolipoproteins; D002308:Cardiolipins; D006023:Glycoproteins; D007074:Immunoglobulin G; D010718:Phosphatidylserines; D053482:beta 2-Glycoprotein I